Uncategorized

Hi, I'm struggling with the clinical differences and the differences in modeling between injury, wound and lesions. For example 'injury of breast' vs 'wound of breast' vs 'breast lesion'. Thank you for pointing this out. Kind regards, Katrien

Wherever a clinical drug concept in the International edition of SNOMED CT uses the term 'international unit' this will be replaced with the internationally recognized abbreviation IU without expansion of this abbreviation. The planned change will be made to 20 clinical drug concepts and the abbreviation IU will be noted as an exception in the Editorial Guide. Please add any comments or feedback to this page by no later than 30th June. Thank you

TNM content of the AJCC has been added to SNOMED in one of the last releases. In the Netherlands we miss some categories that are not used in the USA. If more countries needs this part as well we can ask them to add them to the international release. Else we are in contact with AJCC to be able to add them to our extension. It concerns codes for all possible ycT, ycN, rT, rN and rM categories Are there more countries that also use this part of the TNM categories and needs them in SNOMED? M

Some finding-concept got inactivated with only a replacement by a disorder-concept. For example '16386004 Dry skin (findig)' got replaced by 52475004 |Xeroderma (disorder)| ; The observation and identification of having a dry skin, doesn't always go together with a pathological condition (disorder). My question, is this inactivation temporary and will there be a replacement by a finding concept in the future?

The concept 704497002 |Uses British sign language interpreter (finding)| has been raised for inactivation at the international level. Prior to proceeding with this we are looking for the need for this concept outside of the UK. Would you please advise if British sign language is used in your country.

I'm wondering if other countries have guidelines for brand names in FSN? We more and more can't avoid the use of brand names in FSN, especially in lab domain. For example a KC type analyzer can give slightly different results depending on the brand used.  Our guidelines state not to use brand names in FSN, but I think we will come to exceptions on that guideline. I also read that Snomed Int will add vaccination brands to SNOMED (janssen&janssen, pfizer, astrazenica etc). How do other co

Are there any changes in the SNOMED Int./LOINC agreement or is it still difficult to have new Observables created in the terminology?

With the planning for more frequent releases consideration is being given to how best keep extension managers informed of upcoming content changes. The Early Visibility page has been proposed as the mechanism to meet this need. Current Early Visibility page: https://confluence.ihtsdotools.org/display/RMT/July+2020+Early+Visibility+Release+Notice+-+Planned+changes+to+upcoming+SNOMED+International+Release+packages If you have any comments on this please post them on this page.

I'm raising this here to see how other members feel about some of the concept churn that happens in SCT. Inactivating concepts has always been a thing, but the QI work seems to be producing an even greater amount, and as a result, greater impact on users. Most of the inactivations are fine (hopefully), but they're almost a number that are the result of aligning FSNs to new editorial rules. And since the change in the FSN wasn’t minor, the concept was inactivated and replaced by new conc

Please be advised the abdominal terminology document has now been developed. In this document, we explicitly describe and define concepts relating to regional anatomy of the abdomen and pelvis. The proposed solution addresses the requirement from the diagnostic imaging community and improves the existing terminology content. We would like to get your feedback before we implement the changes in the January 2020 release. Please find the attached PDF file and the link to the Google document.